May 06, 2020
Vanda Pharmaceuticals Reports First Quarter 2020 Financial Results
May 05, 2020
Antengene Announces Expansion of Partnership with Karyopharm in Asia Pacific Markets
Apr 22, 2020
Precision For Medicine Partners With Karyopharm Therapeutics To Initiate New Global Clinical Trial To Treat Patients With COVID-19
Apr 08, 2020
Vanda Pharmaceuticals Inc. And The University of Illinois at Chicago Announce Partnership To Identify Novel Antivirals Against COVID-19
Apr 02, 2020
Vanda Pharmaceuticals Announces the Initiation of ODYSSEY, an FDA Approved Clinical Study of Tradipitant in Hospitalized Patients with Severe COVID-19 Pneumonia
Feb 25, 2020
Vanda Reports results from the EPIONE study of Tradipitant in the treatment of Pruritus in Atopic Dermatitis
Feb 25, 2020
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results
Jan 15, 2020
Global Paclobutrazol Market, 2018-2027: Drivers, Constraints, Opportunities, Threats & Challenges - ResearchAndMarkets.com
Oct 22, 2019
Heron Announces FDA Approval of Supplemental New Drug Application to Expand CINVANTI® Label for Single-Dose Regimen for Patients Receiving Moderately Emetogenic Chemotherapy (MEC)
May 22, 2019
Tradipitant in the Treatment of Gastroparesis: Vanda Presents Clinical Trial Results at DDW 2019
May 01, 2019
Vanda Pharmaceuticals Reports First Quarter 2019 Financial Results
Feb 26, 2019
Heron Announces FDA Approval of Supplemental New Drug Application to Expand CINVANTI® Label for IV Push
Feb 13, 2019
Vanda Pharmaceuticals Reports Fourth Quarter 2018 and Full Year 2018 Financial Results
Oct 16, 2018
BioMarin Receives Milestone Payments from Pfizer for Talzenna® (Talazoparib) for Metastatic Breast Cancer Patients with an Inherited BRCA Mutation
May 18, 2018
BerGenBio to Present Interim Clinical and Biomarker Data With Selective AXL Inhibitor Bemcentinib in AML and MDS at EHA
Apr 09, 2018
Vanda to Present Tradipitant Scientific Posters at the 10th Georg Rajka International Symposium of Atopic Dermatitis
Oct 02, 2017
Vanda to Present Tradipitant Phase II Atopic Dermatitis Data at World Congress of Itch
Sep 13, 2017
Vanda's Tradipitant Improves Itch and Disease Severity in Patients with Atopic Dermatitis